Skip to main content

MoneyWorks4Me

Glaxosmithkline Pharmaceuticals informs about board meeting

15 Jan 2025 Evaluate
Glaxosmithkline Pharmaceuticals has informed that the meeting of the Board of Directors of the Company is scheduled on 10/02/2025 to consider and approve Un Audited financial results for quarter and nine months ended 31st December 2024.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..